Clinical Education InitiativeMenu
Home > Courses > HIV Sexual Networks, Transmission Dynamics, and Drug Resistance

HIV Sexual Networks, Transmission Dynamics, and Drug Resistance

HIV Sexual Networks, Transmission Dynamics, and Drug Resistance
Sorry, this learning module is not available for mobile devices.
Original Presentation: 2/10/2015
Web Posting: 5/4/2015
CE Expiration: 02/10/2018
  • Susan J. Little, MD
    Professor of Medicine
    UCSD Antiviral Research Center, University of California, San Diego, CA
Learning Objectives
At the completion of this educational session, participants will:
  1. Know how HIV phylogenetics are used to infer a transmission network.
  2. Appreciate the frequency and cluster characteristics of HIV transmitted drug resistance.
  3. Understand the structure and dynamics of the HIV transmission network in a population of predominantly men who have sex with men in San Diego.
  4. Be aware of network-focused methods that may improve the efficiency of treatment and prevention interventions for HIV.
Presenter Bio
Susan J. Little, MD
Susan Little is a Professor of Medicine in the Department of Medicine, Division of Infectious Diseases, at the University of California, San Diego (UCSD).  She conducts translational clinical research focused on the pathogenesis, prevention and treatment of acute and very recent HIV infection. Dr. Little is the director of the Primary Infection Research Program at UCSD, working to evaluate the epidemiologic, behavioral, biologic, virologic, and host factors that contribute to HIV transmission. She has been heavily involved in the design of novel approaches to screen and identify acutely infected individuals, and use of molecular epidemiologic methods to infer and characterize HIV transmission networks. Her current research is focused on the evaluation of treatment and prevention interventions directed to network hubs to reduce incident infections. She is actively involved in the training and mentoring of students, post-doctoral research fellows and junior faculty and is an active investigator in the UCSD AIDS Clinical Trials Group.
Continuing Education Credit

This CME activity was approved for AMA PRA Category 1 Credit™ on February 10, 2015 and will terminate February, 2018.

The target audience is all physicians, NPs and PAs involved or interested in HIV education.

This online video and post-activity evaluation are one hour in length. 

  • After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz. 
  • You must achieve at least 70% correct to receive your CME certificate. 
  • If successful, you will be provided instructions to print your CME certificate at the completion of this activity. 

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.

The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with extent of their participation in the activity.

Disclosure Statement 

Policies and standards of MSSNY require that speakers and planners for CME activities disclose any relevant financial relationships they may have with commercial interests whose products, devices or services may be discussed in the content of a CME activity.  

  • Dr. James Braun (Planner/Course Director) had no relevant financial relationships to disclose. 
  • Dr. Little (Presenter) had no relevant financial relationships to disclose. Dr. Little supported her presentation and clinical recommendations with the best available evidence from the medical literature, and submitted her slides in advance for adequate peer review.

Financial Support

This meeting of the Physicians’ Research Network (PRN) and enduring material were funded in part by educational grants from: Bristol-Myers Squibb, Gilead Sciences, Janssen Pharmaceuticals, Merck & Co, and ViiV Healthcare.

PRN Learning Modules